GLI ANTAGONISTI DELLA IL-6 RIDUCONO LA MORTALITA’ DA COVID-19 NEGLI OSPEDALIZZATI: UNA META-ANALISI DAL GRUPPO WHO

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19. A Meta-analysis The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Key PointsQuestion  Is administration of IL-6 antagonists associated with 28-day all-cause mortality in patients hospitalized for COVID-19? Findings  This prospective meta-analysis of 27 randomized trials included 10 930 patients, of whom 2565…